3.68
                                            Schlusskurs vom Vortag:
              $3.84
            Offen:
              $3.88
            24-Stunden-Volumen:
                606.73K
            Relative Volume:
              0.38
            Marktkapitalisierung:
                $239.27M
            Einnahmen:
              -
            Nettoeinkommen (Verlust:
              $-60.36M
            KGV:
              -0.8375
            EPS:
                -4.394
            Netto-Cashflow:
                $-15.05M
            1W Leistung:
              -6.36%
            1M Leistung:
              -6.36%
            6M Leistung:
                +150.34%
            1J Leistung:
              -15.98%
            Zura Bio Ltd Stock (ZURA) Company Profile
Firmenname
                  
                      Zura Bio Ltd
                    
                Sektor
                  Branche
                  Telefon
                  
                      858-247-0520
                    
                Adresse
                  
                      4225 EXECUTIVE SQUARE, LA JOLLA
                    
                Vergleichen Sie ZURA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV | 
|---|---|---|---|---|---|---|
| 
                         
                          
                                ZURA
                            
                             
                        Zura Bio Ltd 
                           | 
                    3.68 | 249.67M | 0 | -60.36M | -15.05M | -4.394 | 
| 
                         
                          
                                VRTX
                            
                             
                        Vertex Pharmaceuticals Inc 
                           | 
                    426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 | 
| 
                         
                          
                                REGN
                            
                             
                        Regeneron Pharmaceuticals Inc 
                           | 
                    642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 | 
| 
                         
                          
                                ALNY
                            
                             
                        Alnylam Pharmaceuticals Inc 
                           | 
                    434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 | 
| 
                         
                          
                                ARGX
                            
                             
                        Argen X Se Adr 
                           | 
                    826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 | 
| 
                         
                          
                                INSM
                            
                             
                        Insmed Inc 
                           | 
                    186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 | 
Zura Bio Ltd Stock (ZURA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung | 
|---|---|---|---|
| 2024-11-04 | Eingeleitet | Leerink Partners | Outperform | 
| 2024-09-05 | Eingeleitet | H.C. Wainwright | Neutral | 
| 2024-05-03 | Eingeleitet | Piper Sandler | Overweight | 
| 2023-10-10 | Eingeleitet | Ladenburg Thalmann | Buy | 
| 2023-08-25 | Eingeleitet | Oppenheimer | Outperform | 
| 2023-06-22 | Eingeleitet | Guggenheim | Buy | 
| 2023-06-14 | Eingeleitet | Chardan Capital Markets | Buy | 
| 2023-05-24 | Eingeleitet | Raymond James | Strong Buy | 
                    Alle ansehen
                    
                  
                Zura Bio Ltd Aktie (ZURA) Neueste Nachrichten
Risk adjusted return profile for Zura Bio Limited analyzedJuly 2025 Snapshot & Free Real-Time Market Sentiment Alerts - newser.com
Predicting Zura Bio Limited trend using moving averages2025 Institutional Moves & Risk Controlled Swing Trade Alerts - newser.com
How supply chain issues affect Zura Bio Limited stockRate Hike & Long-Term Safe Investment Ideas - newser.com
Can technical indicators confirm Zura Bio Limited’s reversalJuly 2025 Drop Watch & Smart Allocation Stock Reports - newser.com
Will Zura Bio Limited (94E) stock beat growth indexesEarnings Overview Summary & Smart Money Movement Alerts - newser.com
Will Zura Bio Limited (94E) stock justify high valuationEarnings Beat & Technical Buy Zone Confirmation - newser.com
Custom strategy builders for tracking Zura Bio LimitedIPO Watch & Long-Term Capital Growth Strategies - newser.com
Zura Bio And 2 Other Promising Penny Stocks For Your Watchlist - Yahoo Finance
Will Zura Bio Limited stock maintain growth storyProfit Target & Fast Gain Swing Trade Alerts - newser.com
Can swing trading help recover from Zura Bio Limited lossesGDP Growth & AI Forecast Swing Trade Picks - newser.com
Will Zura Bio Limited (94E) stock keep high P E multiplesTrade Entry Summary & Safe Entry Point Identification - newser.com
Published on: 2025-10-27 01:30:49 - newser.com
Order flow analysis tools used on Zura Bio LimitedTake Profit & Low Risk Entry Point Tips - newser.com
Combining price and volume data for Zura Bio LimitedWeekly Profit Recap & Daily Volume Surge Signals - newser.com
How to escape a deep drawdown in Zura Bio LimitedExit Point & Consistent Return Investment Signals - newser.com
Building trade automation scripts for Zura Bio LimitedJuly 2025 Recap & Safe Capital Investment Plans - newser.com
What drives Zura Bio Limited stock priceStock Buyback Updates & Budget Friendly Stock Tips - earlytimes.in
How to build a custom watchlist for Zura Bio LimitedGold Moves & Fast Exit Strategy with Risk Control - newser.com
Hidradenitis Suppurativa Clinical Trial Analysis: Key Insights into Rich Pipeline Featuring 24+ Companies and 26+ Therapies | DelveInsight - GlobeNewswire Inc.
Can you recover from losses in Zura Bio Limited2025 Trade Ideas & Weekly Watchlist for Hot Stocks - newser.com
Will Zura Bio Limited (94E) stock profit from AI boomTrade Exit Summary & Low Risk High Win Rate Picks - newser.com
Momentum divergence signals in Zura Bio Limited chartJuly 2025 Trends & Free Low Drawdown Momentum Trade Ideas - newser.com
Aug Spikes: Is Zura Bio Limited stock attractive for retirement portfoliosQuarterly Market Review & Free Accurate Trade Setup Notifications - Trung tâm Dự báo KTTV quốc gia
Will Zura Bio Limited stock remain a Wall Street favorite2025 Market WrapUp & Fast Gain Swing Trade Alerts - Trung tâm Dự báo KTTV quốc gia
How Zura Bio Limited stock compares to market leadersMarket Risk Report & Safe Swing Trade Setups - nchmf.gov.vn
Will Zura Bio Limited stock outperform Dow Jones indexEarnings Performance Report & Free Low Drawdown Momentum Trade Ideas - newser.com
Vor Biopharma's Telitacicept: A Pipeline In Itself? - RTTNews
Zura Bio CEO Takes Medical Leave, Interim Appointed - The Globe and Mail
Zura Bio Ltd (94E.SG) stock price, news, quote and history - Yahoo
Zura Bio slips after CEO announces medical leave (ZURA:NASDAQ) - Seeking Alpha
Zura Bio Ltd Announces Interim CEO Appointment - TradingView
Zura Bio LtdCEO Robert Lisicki to take medical leaveSEC filing - MarketScreener
Zura Bio Limited Announces Executive and Board Changes, Effective October 10, 2025 - MarketScreener
[8-K] Zura Bio Ltd Reports Material Event | ZURA SEC FilingForm 8-K - Stock Titan
Is Zura Bio Limited still worth holding after the dip2025 Buyback Activity & Weekly Return Optimization Alerts - newser.com
Visual analytics tools that track Zura Bio Limited performance2025 Price Momentum & Long-Term Safe Return Strategies - newser.com
Zura Bio Ltd (94E.SG) Stock Price, News, Quote & History - Yahoo
Zura's Make-or-Break Year Ahead: Will TibuSHIELD And TibuSURE Trials Deliver Or Disappoint? - RTTNews
Finanzdaten der Zura Bio Ltd-Aktie (ZURA)
Umsatz
Nettogewinn
Free Cashflow
ENV
        In Yahoo öffnen
        |
        In Google öffnen
            |
            In Finviz öffnen
        |
        In MarketWatch öffnen
            |
            Öffnen Sie in EDGAR    
        |
        Offen in Reuters
    
    
                Kapitalisierung:
                 
                  | 
                Volumen (24h):